Table: Torii Pharmaceutical - Q1 parent results
Apr 26 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2024 Mar 31, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 13.45 11.81 58.60
(+13.9 pct) (+7.8 pct) (+7.3 pct)
Operating 1.38 loss 437 mln 5.80
(+15.2 pct)
Recurring 1.17 loss 404 mln 6.20
(+16.8 pct)
Net 878 mln loss 288 mln 4.70
(+14.1 pct)
EPS 31.27 yen loss 10.28 yen 167.23 yen
Ann Div 120.00 yen 120.00 yen
-Q2 div 50.00 yen 60.00 yen
-Q4 div 70.00 yen 60.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)